Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
14.20
+0.89 (6.69%)
Jun 27, 2025, 4:15 PM AEST

Neuren Pharmaceuticals Market Cap

Neuren Pharmaceuticals has a market cap or net worth of 1.60 billion as of June 27, 2025. Its market cap has decreased by -34.02% in one year.

Market Cap
1.60B
Enterprise Value
1.38B
Revenue
216.83M
Ranking
n/a
PE Ratio
11.90
Stock Price
14.20

Market Cap Chart

Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.60B, an increase of 7,558.16%. That is a compound annual growth rate of 23.72%.

History

DateMarket Cap% Change
Jun 18, 20251.60B0.94%
Dec 31, 20241.59B-50.04%
Dec 29, 20233.18B217.33%
Dec 30, 20221.00B110.88%
Dec 31, 2021474.89M222.46%
Dec 31, 2020147.27M-40.72%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 116.80B
Pro Medicus 29.18B
Cochlear 19.32B
Sonic Healthcare 12.56B
Telix Pharmaceuticals 8.25B
Ramsay Health Care 8.21B
Ansell 4.35B
Regis Healthcare 2.34B
Market Cap Rankings